Table:
begin	end	state
1	19	cytoplasmic
20	40	transmembrane
41	83	non-cytoplasmic
84	102	transmembrane
103	122	cytoplasmic
123	144	transmembrane
145	163	non-cytoplasmic
164	183	transmembrane
184	194	cytoplasmic
195	214	transmembrane
215	219	non-cytoplasmic
220	252	transmembrane
253	263	cytoplasmic
264	291	transmembrane
292	310	non-cytoplasmic
311	339	transmembrane
340	351	cytoplasmic
352	368	transmembrane
369	387	non-cytoplasmic
388	411	transmembrane
412	431	cytoplasmic
432	453	transmembrane
454	458	non-cytoplasmic
459	475	transmembrane
476	494	cytoplasmic
495	513	transmembrane
514	519	non-cytoplasmic
520	544	transmembrane
545	550	cytoplasmic
551	570	transmembrane
571	575	non-cytoplasmic
576	599	transmembrane
600	611	cytoplasmic
612	635	transmembrane
636	640	non-cytoplasmic

Input:
>8501197 DvMF_1931 TRAP dicarboxylate transporter, DctM subunit (RefSeq)
MSERNTFSWATANEWLEKPFLVAGLMVMILAITYQTGFRYSMATINEMLNDAGTVAFLAR
FVDVEGLKAGLQRIIGWSVWSEELSRYLFIWISYLAVPLAIMKRSNIRVDVLCAKLPPRA
QGMAWVVVDVCTLVLTGALCYMGFGHVQMQIAMPQTTPAMGIKYFIPYMILPVGFFLMTL
RTVQDLVRQARTMPALDVVGGVACGLLLFLPVLLSDQWSAVWLLFGYFVLFLLVGVPIAF
SLGLATIATVLGAGTLPLEYLAQIAFVSIDSFPILAIPFFIAAGVFMGAGGLSRRLLALG
DELVGALPGGMALATIVTCMFFAAISGSGPATVAAIGSITIPAMVERGYDKFFAAAVVAS
AGCIGVMIPPSNPFVVYGVAAQASVGKLFLAGIVPGVLCGLALMAVAYYISLKKGWRGEA
RHRDFRSVMQAMWEAKWALLVPVIVLGGIYGGIMTPTEAAAVSALYGMIVGLFIYREITW
RRMWDCMVESAQTSSVIIVLMAMATLFGNIMTIEQVPDHIAAMILGVTSNKIAILLLINV
FLLWVGTFMEALAAIVIITPILLPLVTQVGVDPIHFGVIMVVNLAIGFITPPVGVNLFVA
SSISKVSIGDVVRAAWPFLLVMIALLMAITYIPAISLCLL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server